Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Brian G.M. Durie, Sydney E. Salmon · Cancer · 1975 · 3.1K citations

Medicine, Hematology, Oncology +15

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

Medicine, Oral Pathology, Oral Surgery +12

American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma

James R. Berenson, Bruce E. Hillner, Robert A. Kyle et al. · Journal of Clinical Oncology · 2002 · 542 citations

Medicine, Oncology, Pharmacotherapy +15

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

James R. Berenson, Lee S. Rosen, Anthony Howell et al. · Cancer · 2001 · 532 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Bisphosphonate‐associated osteonecrosis of mandibular and maxillary bone

César A. Migliorati, Mark M. Schubert, Douglas E. Peterson et al. · Cancer · 2005 · 488 citations

Medicine, Oral Medicine, Oral Surgery +17